Jersey vs United Kingdom of Great Britain and Northern Ireland: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Jersey
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Jersey rank
167th
United Kingdom of Great Britain and Northern Ireland rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Jersey
- United Kingdom of Great Britain and Northern Ireland
How they compare
Jersey currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
Across all 10 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.
Jersey ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
Head to head by decade
| Decade | Jersey | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Jersey or United Kingdom of Great Britain and Northern Ireland?
- Jersey, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Jersey and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Jersey ahead.
- How many years of comparable data are there for Jersey and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Jersey and United Kingdom of Great Britain and Northern Ireland rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Jersey ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.